JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

YPF (NYSE:YPF) +0.8% in Friday's trading after earlier rising to a new 52-week high of $47.43, after J.P. Morgan upgrades the ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/98.DhP-XEBZ.js ...

Illumina’s Q4 revenue in 2024 was up 1% from the same period in 2023, totalling $1.1bn. Despite the positive end to the year, ...

Expected Solana and XRP ETFs could attract sizable investment, JP Morgan analysts said, but it's unlikely they'll match the ...

The research team at J.P. Morgan is out with the firm's 2025 Year Ahead Best Idea list, and we found five companies that look ...

The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal ...

Teva Pharmaceutical Industries Limited ( NYSE: TEVA) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 11:15 AM ET Richard Francis - President and CEO Eric Hughes - Head of R&D and Chief ...